Nuvectis Pharma News

Nuvectis Pharma | 8-K: Nuvectis Pharma, Inc. Reports First Quarter 2024 Financial Results and Business Highlights

May 7 08:14

Nuvectis Pharma | DEFA14A: Others

Apr 29 15:38

Nuvectis Pharma | DEF 14A: Definitive information statements

Apr 29 15:36

Nuvectis Pharma | 8-K: Current report

Mar 5 07:22

Nuvectis Pharma | 8-K: Nuvectis Pharma, Inc. Reports Third Quarter 2023 Financial Results and Business Highlights

Nov 8, 2023 07:39

Nuvectis Pharma | 8-K: Current report

Sep 12, 2023 07:16

Nuvectis Pharma | 8-K: Current report

Aug 17, 2023 08:18

Nuvectis Pharma | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Aug 9, 2023 15:51

Nuvectis Pharma | 8-K: Nuvectis Pharma, Inc. Reports Second Quarter 2023 Financial Results and Business Highlights

Aug 9, 2023 15:29

Nuvectis Pharma | 8-K: Current report

Jul 3, 2023 07:00

Nuvectis Pharma | 8-K: Current report

Jun 16, 2023 15:45

Nuvectis Pharma | 8-K: Current report

May 15, 2023 07:22

Nuvectis Pharma | 8-K: Nuvectis Pharma, Inc. Reports First Quarter 2023 Financial Results and Business Highlights

May 10, 2023 08:25

Nuvectis Pharma | DEF 14A: Definitive proxy statements

Apr 28, 2023 15:05

Nuvectis Pharma | S-3: Registration statement for specified transactions by certain issuers

Mar 17, 2023 15:31

Nuvectis Pharma | 8-K: Current report

Mar 7, 2023 10:31

Nuvectis Pharma | 8-K: Nuvectis Pharma, Inc. Reports Third Quarter 2022 Financial Results and Business Highlights

Nov 8, 2022 08:08

Nuvectis Pharma | S-1: General form for registration of securities under the Securities Act of 1933

Aug 15, 2022 08:09

Nuvectis Pharma | 8-K: Nuvectis Pharma, Inc. Reports Second Quarter 2022 Financial Results and Business Highlights

Aug 5, 2022 07:09

Nuvectis Pharma | 8-K: Current report

Jul 29, 2022 16:25